BioMarker Strategies Nets More VC Financing


	Subscribe \| Contact Us \|

Thursday, September 29, 2011 5:54:00 AM PDT | VentureDeal Staff

Baltimore, Maryland -- Biotechnology company BioMarker Strategies has landed $2.3 million in new venture capital investment, according to an SEC regulatory filing.

BioMarker is a cancer diagnostics company that is developing a new live-tumor-cell biomarker testing system.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

BioMarker is still seeking an additional $1.67 million in financing, according to the filing.

Email Page | Print Page

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.